![]() |
|
|
Nutrient Requirements and Functions Laboratory, Beltsville Human Nutrition Research Center, U.S. Department of Agriculture, ARS, Beltsville, MD 20705
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: Keshan disease cardiomyopathy myocarditis oxidative stress vitamin E viral evolution
| INTRODUCTION |
|---|
|
|
|---|
Thus, on June 2, 1992, Dr. Beck faxed me a letter indicating that she had a mouse model of coxsackievirus infection in her laboratory. In her letter, she asked whether her laboratory could offer any assistance "... including using a mouse model of Se deficiency to study coxsackievirus infection." Not knowing anything about coxsackievirus in particular and very little about viruses in general, but nonetheless aware of a possible link between viral infection and Keshan disease, I indicated my interest to participate in such a joint project.
And so we were on our way. By July 1992, animal protocols were in place and approved and mice were ordered in August. Preliminary results were available in September. On October 13, 1992, Melinda paid a visit to Beltsville so we could meet and discuss our results. She also presented a seminar about our findings. A little more than four months after initial contact, our work was being discussed in a public forum! This time line demonstrates one of the major advantages of collaborative interdisciplinary research, namely, the ability to get things moving quickly by joining two diverse areas of expertise. Without one anothers help and support, it would have been very difficult if not impossible for either one of us alone to accomplish this work so rapidly, and certainly the research was conducted much more efficiently by working in tandem.
| Se, vitamin E, and viral myocarditis |
|---|
|
|
|---|
The first observation confirmed what the Chinese scientists had already reported, namely, that the cardiotoxicity of a virulent coxsackievirus was increased in Se-deficient mice. The observation that attracted the most interest, however, was #2 above, that is, the fact that a normally benign strain of coxsackievirus B3, CVB3/0, could be converted to cardiovirulence as a result of feeding the host a Se-deficient diet. This was a novel finding with many potentially important implications. What the results seemed to say was that one could be immersed in a sea of benign coxsackievirus without any apparent ill effects until one suffered a decline in Se nutriture to the point that the virus would exhibit its cardiovirulent properties. This seemed a rather unsettling prospect. Nevertheless, the data appeared to fit what one might expect for a regional endemic disease such as Keshan disease. The viral infectious agent could exist silently everywhere in the environment because of its lack of pathogenicity except in those areas in which the inhabitants had poor Se status.
Observations #3 and #4 showed that deficiency of vitamin E could also lead to increases in viral virulence. These results were important because they showed that factors other than Se had to be considered when attempting to predict the effect of a particular diet on the ability of a host to resist viral infection. Of course, we selected vitamin E for testing in the coxsackie/mouse model because of its well-known close metabolic relationship with Se.
| Oxidative stress |
|---|
|
|
|---|
Although we had several lines of evidence consistent with the idea that
the increased coxsackie virulence we observed by manipulation of host
diet was due to increased oxidative stress, perhaps the most persuasive
data in support of this concept came from an experiment with
N,N'-diphenyl-p-phenylenediamine
(DPPD). DPPD, like vitamin E, is a potent fat-soluble antioxidant.
Although it is a synthetic compound that bears no structural
resemblance to vitamin E, DPPD is nevertheless at least as active as
vitamin E in many models. DPPD was more potent than vitamin E in
restoring reproductive ability in vitamin Edeficient rats of proven
sterility (Draper et al. 1964
) and was more powerful
than vitamin E in decreasing cisplatin-induced lipid peroxidation
in rat kidney (Sugihara et al. 1987
). DPPD prolonged
viability of neonatal rat heart myocytes cultured in the presence of
Adriamycin (Ollinger and Brunmark 1994
) and decreased
the tissue damage in isolated rat hearts perfused with medium
containing hydrogen peroxide (Onodera et al. 1992
). DPPD
has also been shown to inhibit the early stage of hepatocarcinogenesis
in rats fed a choline-deficient L-amino aciddefined
diet containing ethionine (Kobayashi et al. 1996
) and to
slow the progression of atherosclerosis in cholesterol-fed rabbits
(Sparrow et al. 1992
) or apoprotein E-deficient mice
(Tangirala et al. 1995
). In all of these experiments,
the beneficial effect of DPPD was thought to be due to its strong free
radical scavenging activity.
Over the years, the authors laboratory had tested the effect of DPPD
a number of times to investigate whether oxidative stress was involved
in a particular physiologic phenomenon. Either vitamin E or DPPD
protected rats against the toxicity of high levels of selenium when fed
with methionine (Levander and Morris 1970
). DPPD also
prevented the decreased deformability of red blood cells seen in
vitamin Edeficient rats poisoned with lead (Levander et al. 1977
), protected against the toxicity of methyl mercury in rats
(Welsh 1979
) and blocked the pronounced suppressive
effect of a strongly prooxidant vitamin Edeficient diet containing
fish oil against the malarial parasite (Levander et al. 1995
).
With this background, it was a logical extension of earlier work
to determine whether DPPD would protect against the increased
cardiopathology observed in vitamin Edeficient mice infected with
CVB3/20. For these studies, mice were fed a vitamin Edeficient
casein-based diet containing 4% menhaden oil and 1% stripped corn
oil or the same diet supplemented either with 35 mg vitamin E/kg diet
or with an equimolar amount of DPPD. After 4 wk of feeding, the mice
were inoculated with CVB3/20. Ten days postinfection, heart
histopathology scores were lower, indicating less damage in the vitamin
Esupplemented group than in the vitamin Edeficient group and were
lower still in the DPPD group (Beck 1997
and 1998
).
Both of us were now persuaded that oxidative stress was responsible for the increased cardiotoxicity of the coxsackievirus that was observed in our selenium- or vitamin Edeficient mice. No other hypothesis seemed to accommodate all our data. But what was the mechanism whereby the dietary oxidative stress enabled the virus to exert a greater cardiotoxic effect? To me, the most straightforward explanation was that the nutritional deficiencies rendered the host cardiomyocytes more vulnerable to viral attack. Dr. Beck, however, suggested that maybe the heightened oxidative stress in the host cells might in some way have a direct effect on the virus itself. To test this hypothesis, we carried out the "passage experiment."
In this experiment, the benign strain of the virus (CVB3/0) was inoculated initially into either Se-supplemented or Se-deficient mice. After 10 d, the hearts of the mice in both groups were excised and virus was isolated from the heart tissue and passed through HeLa cells in culture. Virus was then harvested from the HeLa cells and inoculated into a second series of mice, all fed a normal diet. Virus that had been passed through Se-supplemented mice during the first half of the experiment (CVB3/0Se+) caused no apparent heart damage when inoculated into the second series of mice. Viruses initially passed through Se-deficient mice (CVB3/0Se-), however, caused significant heart damage when inoculated into a second series of (normal) mice.
| The genome |
|---|
|
|
|---|
The coxsackievirus genome is ~7500 nucleotides long. Although the
CVB3 genome sites that actually determine cardiovirulence remain to be
established, Beck et al. (1995)
found that the virulent
CVB3/0Se- differed from the avirulent CVB3/0 in
six of seven positions that were thought to influence cardiovirulence.
The newly produced cardiovirulent strain,
CVB3/0Se-, had a genomic structure identical to
that of the virulent strain CVB3/20 except for one nucleotide position.
Also worth noting is the fact that the same exact base changes took
place when the CVB3/0 was passed through vitamin Edeficient mice
(Beck et al. 1996
). Because of the diversity in the
identity and location of the genomic differences between the benign and
virulent CVB3 strains, it was difficult to postulate a biochemical
mechanism by which those changes might be taking place.
Mechanistic considerations aside, the discovery by Beck et al. (1995)
that the nutritional status of the host could affect the
genetics of an invading pathogen has profound implications from the
public health point of view. The study of nutrition/infection
interactions is not new; the classic monograph in this field
was published more than three decades ago by Scrimshaw et al. (1968)
. In all of these studies and those that followed,
however, effects of host diet on the ability of the host to resist
infection were always discussed in terms of nutritional effects on the
host immune system. The influence of host diet was considered always in
terms of effect on the host (Fig. 1
). Nothing was said concerning the possible effect of host diet on the
pathogen itself. The fact that Beck et al. (1995)
provide evidence for the latter constitutes a radical shift in how
nutritionists should view the role of diet in determining the outcome
of infectious disease. It seems possible that some old observations may
have to be reinterpreted in light of these new findings.
|
| The present |
|---|
|
|
|---|
Dr. Allen Smith, collaborating with the author at Beltsville, has
initiated a series of investigations into the ability of gold compounds
to increase viral virulence. Earlier work had shown that aurothiomalate
(ATM) could potentiate the virulence of a number of viruses, including
the coxsackievirus (Kabiri et al. 1978
). Because
aurothioglucose (ATG) is now known to be a potent inhibitor of many
selenoenzymes, it seemed reasonable to hypothesize that the
virulence-increasing activity of ATM might be due to that property.
Thioredoxin reductase (TR) was much more sensitive to inhibition by ATG
in vitro than was glutathione peroxidase (GPX) (Hill et al. 1997
). We were able to confirm this differential sensitivity of
TR vs. GPX to ATG in whole-animal experiments (Smith et al. 1999a
). In fact, by careful ATG dose selection, it was possible
to inhibit TR activity strongly in a variety of mouse tissues (heart,
liver, pancreas and kidney) while still having only a minimal effect on
GPX in these organs. These results suggested that TR activity may be
more important in determining viral virulence than GPX activity. On the
other hand, Dr. Smith showed that both ATM and ATG inhibited TR
activity in vivo but that only ATM induced virulence in an avirulent
strain of coxsackievirus B3 (CVB3/0) (Smith et al. 1999b
). Dr. Paul South, working in the authors laboratory,
found that administration of subacute doses of either mercuric chloride
or sodium arsenite caused CVB3/0 to exhibit virulence, and both
compounds also had inhibitory effects on TR (South et al. 1999
). Dr. Beck tested the effect of CVB3/0 on mice that had
their gene for GPX-1 disrupted (Beck et al. 1998
). A
little over half of the GPX-1 "knockout" mice suffered cardiac
damage from CVB3/0, whereas there was no damage in the wild-type
mice. Additional work is required to clarify the roles of TR vs. GPX in
determining an organisms ability to withstand oxidative stress and
resist viral infection.
| The future |
|---|
|
|
|---|
Much work remains to be done to establish the scope of nutrition/viral infection interactions. Additional research to determine the effect of oxidative stress on other viral infections is urgently needed. Dr. Smith has started to look at effects of deficiencies of nutrients other than Se or vitamin E on viral infection; this other facet of the interaction also clearly demands more attention. It is hoped that answers to some of these pressing questions can be obtained in the not too distant future.
| Epilogue |
|---|
|
|
|---|
Fortunately, the Beck/Levander collaboration has by and large achieved that balance with each participant receiving a share of the credit. Both parties desire that the collaboration should continue but even if this is not possible, the collaboration will have fulfilled its goals of initiating a new field of endeavor and establishing the career of a young scientist.
| FOOTNOTES |
|---|
2 Abbreviations used: apo, apoprotein; ATG, aurothioglucose; ATM, aurothiomalate; CVB3, coxsackievirus B3; DPPD, N,N'-diphenyl-p-phenylenediamine; GPX, glutathione peroxidase; TBARS, thiobarbituric acid reactive substances; TR, thioredoxin reductase.
| REFERENCES |
|---|
|
|
|---|
1. Bai J., Wu S., Ge K., Deng X., Su C. The combined effect of selenium deficiency and viral infection on the myocardium of mice. Acta Acad. Med. Sin. 1980;2:29-31
2. Beck M. A. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice. Biomed. Environ. Sci. 1997;10:307-315[Medline]
3. Beck M. A. The influence of antioxidant nutrients on viral infection. Nutr. Rev. 1998;56:S140-S146[Medline]
4.
Beck M. A., Esworthy R. S., Ho Y. S., Chu F. F. Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J 1998;12:1143-1149
5. Beck M. A., Kolbeck P. C., Rohr L., Shi Q., Morris V. C., Levander O. A. Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 1994a;43:166-170[Medline]
6. Beck M.A., Kolbeck P.C., Rohr L.H., Shi Q., Morris V.C., Levander O.A. Vitamin E deficiency intensifies the myocardial injury of coxsackievirus B3 infection in mice. J. Nutr. 1994b;124:345-358
7. Beck M. A., Kolbeck P. C., Shi Q., Rohr L. H., Morris V. C., Levander O. A. Increased virulence of a human enterovirus (coxsackievirus B3) in selenium-deficient mice. J. Infect. Dis. 1994c;170:351-357[Medline]
8. Beck M. A., Shi Q., Morris V. C., Levander O. A. Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1995;1:433-436[Medline]
9. Beck M. A., Shi Q., Morris V. C., Levander O. A. From avirulent to virulent: vitamin E deficiency in mice drives rapid genomic evolution of a coxsackie B3 virus. FASEB J 1996;10:A191(abs.)
10. Boelaert J. R., Gordeuk V. R., Piette J., Weiberg G. A. Conference report: International Conference on HIV and Iron, Brugge. Trop. Med. Int. Health 1997;2:1102-1106[Medline]
11. Bonkovsky H. L. Therapy of hepatitis C: other options. Hepatology 1997;26:143S-151S[Medline]
12. Draper H. H., Bergan J. G., Chiu M., Csallany A. C., Boaro A. V. A further study of the specificity of the vitamin E requirement for reproduction. J. Nutr. 1964;64:395-400
13. Hill K. E., McCollum G. W., Burk R. F. Determination of thioredoxin reductase activity in rat liver supernatant. Anal. Biochem. 1997;253:123-125[Medline]
14. Kabiri M., Basiri E., Kadivar D. Potentiation of coxsackievirus B3 infection in adult mice pretreated with a gold salt. J. Med. Virol. 1978;3:125-136[Medline]
15. Kahn R. L., Prager D. J. Interdisciplinary collaborations are a scientific and social imperative. The Scientist 1994;8:12
16. Kobayashi E., Tsujiuchi T., Nakae D., Mizumoto Y., Andoh N., Endoh T., Kitada H., Tsutsumi M., Denda A., Konishi Y. Inhibitory effects of N,N'-diphenyl-p-phenylenediamine on the early stage of the enhanced hepatocarcinogenesis caused by coadministration of ethionine and a choline-deficient L-amino acid-defined diet in rats. Exp. Toxicol. Pathol. 1996;48:275-282[Medline]
17. Levander O. A. Nutrition and newly emerging viral diseases: an overview. J. Nutr. 1997;127:948S-950S
18. Levander O. A., Beck M. A. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol. Trace Elem. Res. 1997;56:5-21[Medline]
19. Levander O. A., Fontela R., Morris V. C., Ager A. L., Jr Protection against murine cerebral malaria by dietary-induced oxidative stress. J. Parasitol. 1995;81:99-103[Medline]
20. Levander O. A., Morris V. C. Interactions of methionine, vitamin E, and antioxidants in selenium toxicity in the rat. J. Nutr. 1970;100:1111-1118
21. Levander O. A., Morris V. C., Beck M. A. Dietary iron overload stimulates conversion of a benign coxsackievirus (CVB3/0) to virulence in vitamin E-deficient (-E) mice. FASEB J 1998;12:A845(abs.)
22. Levander O. A., Morris V. C., Ferretti R. J. Filterability of erythrocytes from vitamin E-deficient lead-poisoned rats. J. Nutr. 1977;107:363-372
23. Macrina F. L. Dynamic Issues in Scientific Integrity: Collaborative Research 1995 American Academy of Microbiology Critical Issues Colloquim, American Society for Microbiology Washington, DC.
24.
Metzger N., Zare R. N. Interdisciplinary research: from belief to reality. Science (Washington, DC) 1999;283:642-643
25. Ollinger K., Brunmark A. Effect of different oxygen pressures and N,N'-diphenyl-p-phenylenediamine on adriamycin toxicity to cultured neonatal rat heart myocytes. Biochem. Pharmacol. 1994;48:1707-1715[Medline]
26. Onodera T., Takemura G., Oguro T., Ashraf M. Effect of exogenous hydrogen peroxide on myocardial function and structure in isolated rat heart. Can. J. Cardiol. 1992;8:989-997[Medline]
27. Scrimshaw N. S., Taylor C. E., Gordon J. E. Interactions of Nutrition and Infection 1968 World Health Organization Geneva, Switzerland.
28.
Smith A. D., Guidry C. A., Morris V. C., Levander O. A. Aurothioglucose inhibits murine thioredoxin reductase activity in vivo. J. Nutr. 1999a;129:194-198
29. Smith A. D., Guidry C. A., South P. K., Morris V. C., Levander O. A. Aurothiomalate (ATM) and aurothioglucose (ATG) both inhibit thioredoxin reductase (TR) activity in vivo but only ATM causes a non-virulent strain of coxsackievirus B3 (CVB3/0) to exhibit virulence. FASEB J. 1999b;13:LB233
30. South P. K., Smith A. D., Morris V. C., Levander O. A. An avirulent strain of coxsackievirus B3 causes death in mice pretreated with mercury or arsenic. FASEB J. 1999;13:LB234
31. Sparrow C. P., Doebber T. W., Olszewski J., Wu M. S., Ventre J., Stevens K. A., Chao Y. S. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N'-diphenyl-phenylenediamine. J. Clin. Investig. 1992;89:1885-1891
32. Sugihara K., Nakano S., Koda M., Tanaka K., Fukuishi N., Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn. J. Pharmacol. 1987;43:247-252[Medline]
33.
Tangirala R. K., Casanada F., Miller E., Witztum J. L., Steinberg D., Palinski W. Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 1995;15:1625-1630
34. Welsh S. O. The protective effect of vitamin E and N,N'-diphenyl-p-phenylenediamine (DPPD) against methyl mercury toxicity in the rat. J. Nutr. 1979;109:1673-1681
This article has been cited by other articles:
![]() |
D. L. Illman and F. Clark Visibility of Team Science: A Case Study of Media Coverage of the NSF Science and Technology Centers Science Communication, September 1, 2008; 30(1): 48 - 76. [Abstract] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||